Showing results (201-210 of 330) with videos related to

Sort By:
Pageof 33
JACC. Cardiooncology|August 14, 2025
Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving ImmunotherapyEvaline Cheng, Maja Ivanovic, Antonia Chan, et al.
JACC. Cardiooncology|September 12, 2025
Diagnostic Performance of the New Free Light Chain Ratio in Systemic AmyloidosisPaolo Milani, Giuseppe Damiano Sanna, Claudia Bellofiore, et al.
JACC. Cardiooncology|October 26, 2020
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted TherapyAnthony F Yu, Chaya S Moskowitz, Katherine Lee Chuy, et al.
JACC. Cardiooncology|January 13, 2023
Burden of Cardiovascular Disease in Immune Checkpoint Inhibitor-Treated Patients: Reconciling Adjudicated and Coded OutcomesLavanya Kondapalli, Judith Hsia, Ronni Miller, et al.
JACC. Cardiooncology|January 13, 2023
Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art ReviewGiselle Alexandra Suero-Abreu, Markella V Zanni, Tomas G Neilan
JACC. Cardiooncology|January 13, 2023
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced MyocarditisAlexi Vasbinder, YeeAnn Chen, Adrien Procureur, et al.
JACC. Cardiooncology|January 13, 2023
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After ImmunotherapyCharlotte Lee, Zsofia D Drobni, Amna Zafar, et al.
JACC. Cardiooncology|November 29, 2022
Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness: During or After ChemotherapyGabriela G F van der Schoot, Harm L Ormel, Nico-Derk L Westerink, et al.
JACC. Cardiooncology|November 29, 2022
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell CarcinomaFleur H J Kaptein, Tom van der Hulle, Sander J E Braken, et al.
Pageof 33